89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 51 filers reported holding 89BIO INC in Q2 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $565,290 | -35.2% | 70,573 | -5.9% | 0.00% | 0.0% |
| Q1 2024 | $873,023 | +4.0% | 75,002 | -0.2% | 0.00% | 0.0% |
| Q4 2023 | $839,414 | -7.5% | 75,149 | +27.9% | 0.00% | 0.0% |
| Q3 2023 | $907,548 | -26.8% | 58,779 | -10.2% | 0.00% | -50.0% |
| Q2 2023 | $1,240,202 | +7651.3% | 65,446 | +1412.5% | 0.00% | – |
| Q1 2022 | $16,000 | -76.8% | 4,327 | -17.6% | 0.00% | – |
| Q4 2021 | $69,000 | -33.0% | 5,250 | 0.0% | 0.00% | – |
| Q3 2021 | $103,000 | -59.0% | 5,250 | -60.9% | 0.00% | – |
| Q2 2021 | $251,000 | -15.8% | 13,436 | +6.7% | 0.00% | – |
| Q1 2021 | $298,000 | -2.9% | 12,592 | 0.0% | 0.00% | – |
| Q4 2020 | $307,000 | +21.3% | 12,592 | +27.8% | 0.00% | – |
| Q3 2020 | $253,000 | +181.1% | 9,855 | +117.1% | 0.00% | – |
| Q2 2020 | $90,000 | -21.7% | 4,539 | 0.0% | 0.00% | – |
| Q1 2020 | $115,000 | -2.5% | 4,539 | +1.2% | 0.00% | – |
| Q4 2019 | $118,000 | – | 4,487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 400,000 | $1,288,000 | 6.98% |
| TCG Crossover Management, LLC | 1,133,196 | $3,649,000 | 1.55% |
| GREAT POINT PARTNERS LLC | 1,400,000 | $4,508,000 | 1.08% |
| DAFNA Capital Management LLC | 766,774 | $2,469,000 | 0.67% |
| RA Capital Management | 7,782,669 | $25,060,000 | 0.67% |
| BVF INC/IL | 3,898,000 | $12,552,000 | 0.61% |
| Boxer Capital, LLC | 1,400,000 | $4,508,000 | 0.29% |
| Orbimed Advisors | 3,658,869 | $11,782,000 | 0.21% |
| Newtyn Management, LLC | 310,000 | $998,000 | 0.19% |
| Orchard Capital Management, LLC | 168,493 | $592,000 | 0.18% |